Darleukin, Fibromun
PHL19IL2TNFCOMB04/24
Phase 2 small_molecule active
Quick answer
Darleukin, Fibromun for locally advanced basal cell carcinoma patients is a Phase 2 program (small_molecule) at Philogen S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Philogen S.p.A.
- Indication
- locally advanced basal cell carcinoma patients
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active